|
|
Subscribe
to our newsletter:
| |
|
|
|
|
Search results for: ether
16 - 20 of 287 <<previous | next>>
Drugs results:
|
Lorazepam is one of a group of drugs known as Benzodiazepines that are Central Nervous System (CNS) depressants. Lorazepam is used to relieve anxiety, and to treat panic disorder.
Be sure to tell your doctor of any allergies you have whether it is to m more...
|
|
Women still capable of childbearing should not use or handle crushed Propecia tablets. Propecia can cause birth defects in male fetuses.
Propecia belongs to the group of medicines called enzyme inhibitors. It is used to treat urinary problems caused b more...
|
|
Soma, also known as Carisoprodol, is a skeletal muscle relaxant used to relax certain muscles in your body and relieve the problems caused by strains, sprains, or other muscular injuries. Soma works in the Central Nervous System (CNS).
Be sure to tell more...
|
|
Valium, may also be called Diazepam, and is one of the Benzodiazepine group of medicines. These are Central Nervous System (CNS) depressants and are used to relieve anxiety. Valium is also used to help relax muscles or relieve muscle spasm. Valium injecti more...
|
|
Xanax is one of a group of medicines known as Benzodiazepines. Benzodiazepines are Central Nervous System (CNS) depressants that are used as antianxiety and antipanic agents, but are also used as antitremor medicines and as a sedative. Xanax may also be more...
|
Diseases results:Mental Health and Depression
Bladder infection
Pain relief
Panic disorder
Rhinitis
Acromegaly
Anesthesia
Acute Lymphoblastic Leukemia
Aplastic anemiaArticles results:
| Federal Judge Denies Vioxx Class Action Status |
Plaintiffs' attorneys had requested a motion for class action status against Merck & Co. for personal injury and wrongful death after taking Vioxx, a painkiller which was taken off the market in 2004 after it was found to raise a patient's risk of heart attack or stroke. Judge Eldon Fallon, New Orleans, denied the request.There are approximately 24,000 lawsuits filed by people who claim to have been harmed because they took Vioxx.
|
| FDA Reaches Tentative Agreement With Pharmaceutical Companies On User Fees To Review Advertisements |
FDA has reached an agreement with the pharmaceutical industry that would require companies to pay fees to the agency for evaluating television advertisements in exchange for quicker reviews of the ads, the Wall Street Journal reports. Under the agreement, pharmaceutical companies would pay FDA $40,000 to $50,000 at the beginning of each year for each television ad campaign they planned to air.
|
| Out Of REACH: New Legislation Threatens Medicines |
Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ drugs - one of them an anticancer therapy- have already warned AZ that they may no longer be able to guarantee supply under the new rules. Pfizer and GlaxoSmithKline have also said they are in discussions with suppliers.
|
| Food And Drug Law Institute Sponsors National Colloquium On Access To Unapproved Drugs |
Should terminally ill patients be allowed access to drugs not approved by the Food and Drug Administration? That is the question a panel of experts will discuss and debate at a landmark Colloquium, Whose Life Is It, Anyway?, sponsored by the Food and Drug Law Institute (FDLI), Feb. 27, 2007, in Washington, D.C. This meeting is the first in a series of colloquia to be sponsored by FDLI in upcoming months.
|
| Microcapsules Like It Hot And Salty |
Scientists at the Max Planck Institute of Colloids and Interfaces have presented a new method with which to precisely control the permeability of microcapsules using the salt content and the temperature of the solution. In order to accomplish this, the researchers developed a theoretical model which exactly describes the processes in the polymer shell of the capsules.
|
16 - 20 of 287 <<previous | next>>
|
|
|
